21
To Evaluate the Effectiveness(Immunogenecity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children
Condition(s): Prophylaxis Against Diphtheria, Tetanus Last Updated: August 29, 2012Recruiting
54 Clinical Trials for: Biological Diphtheria-tetanus Vaccine, Page 2 of 3
Hide Studies Not Seeking New Volunteers
22
Prevention of GBS Colonization Via Immunity
Condition(s): Streptococcus Group B Last Updated: June 7, 2012Completed
23
Traveler's Diarrhea (TD) Automated Process
Condition(s): Prevention of Travelers' Diarrhea Last Updated: March 13, 2012Completed
24
The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients
Condition(s): Pertussis Last Updated: October 22, 2007Enrolling by invitation
25
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
Condition(s): Pertussis; Diphtheria Last Updated: October 13, 2008Completed
26
Gender-Stratified Safety and Immunogenicity Study
Condition(s): Diarrhea Last Updated: March 13, 2012Active, not recruiting
27
Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine
Condition(s): Pneumococcal Infections Last Updated: March 13, 2012Completed
28
Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals
Condition(s): HIV Infections; Hepatitis C Last Updated: July 13, 2012Completed
29
Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Condition(s): HIV Infections Last Updated: May 17, 2012Completed
30
Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
Condition(s): Diphtheria; Tetanus; Whooping Cough; Polio; Haemophilus Influenzae Type b Last Updated: January 26, 2012Completed
31
Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
Condition(s): Tetanus Last Updated: September 24, 2009Terminated
32
Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™
Condition(s): Diphtheria; Tetanus; Pertussis; Polio; Haemophilus Infection Last Updated: January 11, 2010Completed
33
LT Vaccine Patch Self-Administration Study
Condition(s): Prevention of Travelers' Diarrhea Last Updated: March 13, 2012Completed
34
Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan
Condition(s): Diphtheria; Tetanus; Pertussis Last Updated: November 18, 2009Completed
35
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination
Condition(s): Diphtheria; Tetanus; Pertussis Last Updated: September 9, 2009Completed
36
ACE393-103 Vaccination Challenge Study
Condition(s): Campylobacter Infection Last Updated: March 10, 2009Active, not recruiting
37
Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea
Condition(s): Diarrhea Last Updated: March 4, 2011Completed
38
ACE527 Safety and Immunogenicity Study
Condition(s): Enterotoxigenic E. Coli (ETEC) Infection Last Updated: January 28, 2010Completed
39
Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
Condition(s): Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus Last Updated: May 2, 2013Completed
40
Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
Condition(s): Diphtheria, Tetanus, Pertussis, Poliomyelitis & Haemophilus Influenzae Type b Disease; Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines Last Updated: November 8, 2012Completed
